A. George Wilson
Role not yet determined Is this you? Add your title
Also affiliated: University of Kentucky (2015–2024); Medical University of South Carolina (2016); University of Georgia (2011–2015); Indiana University Bloomington (2011–2015); Carilion Clinic (2013–2015); Indiana University (2011–2015); Villanova University (2011); Virginia Tech (2013–2015)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
A. George Wilson's research investigates the behavioral and neuro-economic processes underlying temporal discounting and its relationship to addiction and self-control. His work examines how individuals make decisions involving delayed rewards, particularly in the context of substance use and obesity. Wilson has explored the impact of episodic future thinking on reducing delay discounting and cigarette smoking, and has used purchase tasks to compare real versus hypothetical cigarette valuations. His research also extends to animal models, studying suboptimal choice in rats and prospective memory. Wilson has published 27 works with 1,425 citations and an h-index of 16, and has collaborated with researchers at the University of Arkansas for Medical Sciences including Peter A. Crooks, Justin R. Nickell, Cassie M. Chandler, and John P. Culver.
Metrics
- h-index: 16
- Publications: 27
- Citations: 1,424
Selected Publications
-
Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats (2024)
Collaboration Network
Top Collaborators
- Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats
- Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats
- Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats
- Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats
- Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats
- Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in rats
Similar Researchers
Based on overlapping research topics